Table 1.

Correlation between expression of CRY2 and clinicopathological features in 289 case of colorectal cancer

	All cases	CRY2
		Low expression	Overexpression	P Value
Gender				0.8131
Male	147(50.9)	85(51.5)	62(50.0)
Female	142(49.1)	80(48.5)	62(50.0)
Age2				0.0731
<59	130(45.0)	82(49.7)	48(38.7)
≥59	159(55.0)	83(50.3)	76(61.3)
Histological grade				0.2331
G1	20(6.9)	12(7.3)	8(6.5)
G2	230(79.6)	126(76.4)	104(83.9)
G3	39(13.5)	27(16.4)	12(9.7)
pT status				0.1113
T1	7(2.4)	7(4.2)	0(0.0)
T2	39(13.5)	24(14.5)	15(12.1)
T3	237(82.0)	131(79.4)	106(85.5)
T4	6(2.1)	3(1.8)	3(2.4)
pN status				0.2261
N0	173(59.9)	104(63.0)	69(55.6)
N1	116(40.1)	61(37.0)	55(44.4)
pM status				0.2461
M0	259(89.6)	151(91.5)	108(87.1)
M1	30(10.4)	14(8.5)	16(12.9)
Clinical stage				0.4301
I	30(10.4)	20(12.1)	10(8.1)
II	124(42.9)	73(44.2)	51(41.1)
III	105(36.3)	58(35.2)	47(37.9)
IV	30(10.4)	14(8.5)	16(12.9)
Chemotherapy				0.2211
No	211(73.0)	136(75.6)	75(68.8)
Yes	78(27.0)	44(24.4)	34(31.2)